Clincosm LogoSign in Get a demo

Covid19

Showing NaN - NaN of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting
  • SARS-CoV Infection
  • Covid19
  • SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
  • +5 more
  • Birmingham, Alabama
  • +155 more
Dec 16, 2022

Covid19 Trial in United States (Sotrovimab)

No longer available
  • Covid19
  • Sotrovimab
  • Palo Alto, California
  • +3 more
Nov 4, 2022

Covid19 Trial in United States (sotrovimab)

Recruiting
  • Covid19
  • sotrovimab
  • Riverside, California
  • +9 more
Nov 2, 2022

COVID-19 Respiratory Outcomes Registry

Active, not recruiting
  • Covid19
  • Questionnaires and Patient Reported Outcomes (PROs)
  • +10 more
  • Saint Louis, Missouri
  • +3 more
Oct 11, 2022

Covid19 Trial in United States (Screening testing strategy, No screening testing strategy)

Active, not recruiting
  • Covid19
  • Screening testing strategy
  • No screening testing strategy
  • Hazelwood, Missouri
  • +4 more
Aug 22, 2022

Covid19 Trial in Saint Louis (Text message)

Completed
  • Covid19
  • Text message
  • Saint Louis, Missouri
    Ascension
Jul 18, 2022

Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)

Active, not recruiting
  • Covid19
  • Apixaban 2.5 MG
  • Placebo
  • Phoenix, Arizona
  • +120 more
Jul 1, 2022

Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)

Recruiting
  • Covid19
  • theraputic heparin
  • +4 more
  • Birmingham, Alabama
  • +101 more
Jun 28, 2022

Covid19 Trial in Worldwide (Infliximab, Abatacept, Remdesivir)

Completed
  • Covid19
  • Phoenix, Arizona
  • +90 more
May 3, 2022

Covid19, Coronavirus, Coronavirus Infection Trial in United States (Ebselen, Placebo)

Enrolling by invitation
  • Covid19
  • +3 more
  • New Haven, Connecticut
  • +6 more
Apr 5, 2022

Covid19, Corona Virus Infection, Coronavirus Trial in United States (Ebselen, Placebo)

Enrolling by invitation
  • Covid19
  • +3 more
  • New Haven, Connecticut
  • +6 more
Apr 5, 2022

Covid19, SARS-CoV-2 Infection Trial in Iowa City, Saint Louis (GC4419, Placebo)

Terminated
Has Results
  • Covid19
  • SARS-CoV-2 Infection
  • Iowa City, Iowa
  • +2 more
Mar 14, 2022

Covid19, Anosmia, Olfactory Disorder Trial in Saint Louis (Theophylline Powder)

Completed
  • Covid19
  • +7 more
  • Theophylline Powder
  • Saint Louis, Missouri
    Washington University School of Medicine in Saint Louis
Feb 1, 2022

Covid19, Coronavirus Trial in Canada, United States (Fluvoxamine, Placebo)

Completed
  • Covid19
  • Coronavirus
  • Chicago, Illinois
  • +4 more
Jan 12, 2022

Feasibility Study of Hematology Parameters in COVID-19 Disease

Completed
  • Covid19
  • +3 more
  • CBC-Diff Monocyte Volume Width Distribution
  • Saint Louis, Missouri
    Washington University
Dec 5, 2021

Biomarkers of Trained Immunity Following MMR Vaccination

Completed
  • Covid19
  • Heterologous stimuli
  • Neutralization assay
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 24, 2021

Covid19 Trial in United States (Convalescent Plasma, Saline)

Completed
Has Results
  • Covid19
  • Convalescent Plasma
  • Saline
  • Chandler, Arizona
  • +52 more
Oct 15, 2021

Covid19, Intellectual Disability, Developmental Disability Trial in Baltimore, Kansas City, Saint Louis (General Communication

Recruiting
  • Covid19
  • +3 more
  • General Communication Message
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jul 19, 2021

Anosmia, Covid19, Ageusia Trial in Saint Louis (Smell Training)

Active, not recruiting
  • Anosmia
  • +6 more
  • Smell Training
  • Saint Louis, Missouri
    Washington University School of Medicine in Saint Louis
Apr 2, 2021